User profiles for Lianne Tile
Lianne TileUniversity of Toronto, University Health Network Verified email at uhn.ca Cited by 538 |
[HTML][HTML] Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial
Background Vitamin K has been widely promoted as a supplement for decreasing bone loss
in postmenopausal women, but the long-term benefits and potential harms are unknown. …
in postmenopausal women, but the long-term benefits and potential harms are unknown. …
Atypical femur fractures: current understanding and approach to management
Osteoporosis and resulting osteoporotic fractures are responsible for significant morbidity,
excess mortality, and health care costs in the developed world. Medical therapy for …
excess mortality, and health care costs in the developed world. Medical therapy for …
Garetosmab in fibrodysplasia ossificans progressiva: A randomized, double-blind, placebo-controlled phase 2 trial
…, E Botman, PG Raijmakers, M Al Mukaddam, L Tile… - Nature medicine, 2023 - nature.com
Fibrodysplasia ossificans progressiva (FOP) is a rare disease characterized by heterotopic
ossification (HO) in connective tissues and painful flare-ups. In the phase 2 LUMINA-1 trial, …
ossification (HO) in connective tissues and painful flare-ups. In the phase 2 LUMINA-1 trial, …
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP. 3 …
Background Exemestane can prevent breast cancer in postmenopausal women. Because of
potential widespread use, we examined the safety of exemestane on bone health. Methods …
potential widespread use, we examined the safety of exemestane on bone health. Methods …
Garetosmab Reduces flare-ups in patients with fibrodysplasia ossificans progressiva
…, E Botman, MA Mukaddam, L Tile… - Journal of the …, 2021 - academic.oup.com
XLH is the most common heritable rickets. Affected children have high levels of circulating
FGF23 that cause hypophosphatemia with consequent rickets and lower limb deformity. …
FGF23 that cause hypophosphatemia with consequent rickets and lower limb deformity. …
Garetosmab, an inhibitor of activin A, reduces heterotopic ossification and flare-ups in adults with fibrodysplasia ossificans progressiva: a randomized, double-blind …
…, E Botman, PG Raijmakers, M Al Mukaddam, L Tile… - medRxiv, 2023 - medrxiv.org
Background Fibrodysplasia ossificans progressiva (FOP), an ultra-rare disorder caused by
mutations in the gene encoding activin A receptor type 1 (ACVR1), is characterized by painful …
mutations in the gene encoding activin A receptor type 1 (ACVR1), is characterized by painful …
Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update
Background: In Canada, more than 2 million people live with osteoporosis, a disease that
increases the risk for fractures, which result in excess mortality and morbidity, decreased …
increases the risk for fractures, which result in excess mortality and morbidity, decreased …
Odanacatib for the treatment of osteoporosis
…, H McDonald-Blumer, R Ridout, L Tile… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Osteoporosis and fragility fractures are important public health concerns.
Cathepsin K inhibitors, including odanacatib , are a novel class of medications for osteoporosis …
Cathepsin K inhibitors, including odanacatib , are a novel class of medications for osteoporosis …
Unusual femur stress fractures in children with osteogenesis imperfecta and intramedullary rods on long-term intravenous pamidronate therapy
In this report, we describe 6 children with osteogenesis imperfecta with unusual stress
femoral fractures. All children were on long-term cyclic pamidronate treatment. All fractures …
femoral fractures. All children were on long-term cyclic pamidronate treatment. All fractures …
Validation of a calcium assessment tool in postmenopausal Canadian women
Adequate calcium intake is important for optimal bone health. Assessing dietary calcium
intake, however, is neither widely done nor standardized in North American clinical practices. …
intake, however, is neither widely done nor standardized in North American clinical practices. …